Solve Therapeutics
USEntry
2025
Hold
1yr
Status
Active
Who owns Solve Therapeutics?
Solve Therapeutics is currently owned by Abingworth through Abingworth Bioventures 8 (2021 vintage), since 2025. Across its history, Solve Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
AbingworthAbingworth Bioventures 8 · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQUnited States
SectorBiotech
Ownership history
2 ownership periods
Active
AbingworthActive
2025 · present(1yr) · Abingworth Bioventures 8 · 2021 · Life Sciences VC
General AtlanticActive
present · General Atlantic core growth equity fund · 2013 · Growth
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Solve Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Solve Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Solve Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue